Cat.#: ACPP-1508
| Despition | I TAC Human Recombinant |
| SIZE | 5 µg |
| Purity | > 97.0% (SDS-PAGE) |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1847 | Human GFRA3 Protein (AC1847) | 5 µg | inquiry |
| ACPP-1626 | Human SHC1 Protein (AC1626) | 5 µg | inquiry |
| ACPP-1239 | PDE7B Blocking Peptide (AC1239) | 250 µg | inquiry |
| ACPP-1191 | Nogo Blocking Peptide (AC1191) | 250 µg | inquiry |
| ACPP-1569 | Human SOX2 Protein (AC1569) | 5 µg | inquiry |
| ACPP-1673 | Human TIMM8A Protein (AC1673) | 5 µg | inquiry |
| ACPP-1132 | Recombinant Human Calbindin Protein (AC1132) | 25 µl | inquiry |
| ACPP-1817 | Human NT 4 Protein (AC1817) | 20 µg | inquiry |
| ACPP-1750 | Human LCN1 Protein (AC1750) | 5 µg | inquiry |
| ACPP-1301 | SHISA9 Blocking Peptide (AC1301) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.